Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Rimner

Showing results (161-170 of 272) with videos related to

Pageof 28
Sort By:
JCO Oncology Practice|January 22, 2024
Disparities in Stage at Presentation Among Hispanic and Latinx Patients With Non-Small-Cell Lung Cancer in the United StatesEdward Christopher Dee, Nishwant Swami, Bahaa Kazzi, et al.
Advances in Radiation Oncology|September 12, 2018
Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibitionDonata von Reibnitz, Jamie E Chaft, Abraham J Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012Shannon E Fogh, Snehal Deshmukh, Lawrence B Berk, et al.
Clinical Lung Cancer|May 25, 2022
Rationale and Design of the Phase 3 KEYLYNK-013 Study of Pembrolizumab With Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Limited-Stage Small-Cell Lung CancerAndreas Rimner, Wei-Chu Victoria Lai, Raffaele Califano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 5, 2024
Impact of mediastinal tumor burden and lymphatic spread in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trialEleni Gkika, Cas Stefaan Dejonckheere, Jörg Sahlmann, et al.
Advances in Radiation Oncology|March 5, 2021
Genomic Analyses for Predictors of Response to Chemoradiation in Stage III Non-Small Cell Lung CancerLeo Y Luo, Robert M Samstein, Rosalind Dick-Godfrey, et al.
Clinical Lung Cancer|July 31, 2017
Identifying the Optimal Radiation Dose in Locally Advanced Non-Small-cell Lung Cancer Treated With Definitive Radiotherapy Without Concurrent ChemotherapyMark A Sonnick, Federica Oro, Bernice Yan, et al.
Advances in Radiation Oncology|February 24, 2022
Four-Dimensional Computed Tomography-Based Correlation of Respiratory Motion of Lung Tumors With Implanted Fiducials and an External SurrogateJonas Willmann, Baho Sidiqi, Chunyu Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Effects of Tumor Mutational Burden and Gene Alterations Associated with Radiation Response on Outcomes of Postoperative Radiation Therapy in Non-Small Cell Lung CancerNarek Shaverdian, Annemarie F Shepherd, Xingzhe Li, et al.
International Journal of Radiation Oncology, Biology, Physics|June 22, 2016
Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 StudiesJing Zhao, Ellen D Yorke, Ling Li, et al.
Pageof 28

Showing results (161-170 of 272) with videos related to

Sort By:
Pageof 28
JCO Oncology Practice|January 22, 2024
Disparities in Stage at Presentation Among Hispanic and Latinx Patients With Non-Small-Cell Lung Cancer in the United StatesEdward Christopher Dee, Nishwant Swami, Bahaa Kazzi, et al.
Advances in Radiation Oncology|September 12, 2018
Safety of combining thoracic radiation therapy with concurrent versus sequential immune checkpoint inhibitionDonata von Reibnitz, Jamie E Chaft, Abraham J Wu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 1, 2017
A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012Shannon E Fogh, Snehal Deshmukh, Lawrence B Berk, et al.
Clinical Lung Cancer|May 25, 2022
Rationale and Design of the Phase 3 KEYLYNK-013 Study of Pembrolizumab With Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Limited-Stage Small-Cell Lung CancerAndreas Rimner, Wei-Chu Victoria Lai, Raffaele Califano, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 5, 2024
Impact of mediastinal tumor burden and lymphatic spread in locally advanced non-small-cell lung cancer: A secondary analysis of the multicenter randomized PET-Plan trialEleni Gkika, Cas Stefaan Dejonckheere, Jörg Sahlmann, et al.
Advances in Radiation Oncology|March 5, 2021
Genomic Analyses for Predictors of Response to Chemoradiation in Stage III Non-Small Cell Lung CancerLeo Y Luo, Robert M Samstein, Rosalind Dick-Godfrey, et al.
Clinical Lung Cancer|July 31, 2017
Identifying the Optimal Radiation Dose in Locally Advanced Non-Small-cell Lung Cancer Treated With Definitive Radiotherapy Without Concurrent ChemotherapyMark A Sonnick, Federica Oro, Bernice Yan, et al.
Advances in Radiation Oncology|February 24, 2022
Four-Dimensional Computed Tomography-Based Correlation of Respiratory Motion of Lung Tumors With Implanted Fiducials and an External SurrogateJonas Willmann, Baho Sidiqi, Chunyu Wang, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2022
Effects of Tumor Mutational Burden and Gene Alterations Associated with Radiation Response on Outcomes of Postoperative Radiation Therapy in Non-Small Cell Lung CancerNarek Shaverdian, Annemarie F Shepherd, Xingzhe Li, et al.
International Journal of Radiation Oncology, Biology, Physics|June 22, 2016
Simple Factors Associated With Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy of the Thorax: A Pooled Analysis of 88 StudiesJing Zhao, Ellen D Yorke, Ling Li, et al.
Pageof 28